Abstract
The K562 cell line, which was established from a patient with chronic myeloid leukemia in blast crisis, was thought to be myeloid, but recent data indicate that it is an undifferentiated erythroid cell line. We have found that the glycosphingolipid content of these cells differs considerably from that of mature erythrocytes. Globotetraosylceramide, the most abundant glycolipid of mature red cells, was not detected in K562 cells, and neither was globotriaosylceramide. The predominant neutral glycolipids of K562 cells are monohexaosylceramides, which are a mixture of glucosyl- and galactosylceramides, and lactotriaosyl- and lactoneotetraosylceramides were also detected. Secondly, gangliosides which contain N-acetylgalactosamine were much more abundant than those containing N-acetylglucosamine in K562 cells, in contrast to erythrocytes. The most abundant ganglioside of K562 cells, GM2, is present in trace quantities in erythrocytes. A third major difference between these two cells lies in their relative proportions of neutral glycolipids and gangliosides. The molar ratio of neutral glycolipids/gangliosides is approximately 15:1 in erythrocytes and 1:1 in K562 cells. These striking differences between K562 cells and mature erythroc...Continue Reading
References
Jul 12, 1979·Nature·T R RutherfordD J Weatherall
Mar 20, 1975·Biochimica Et Biophysica Acta·S Hakomori
Nov 29, 1977·Biochemistry·K E Stein, D M Marcus
Jan 1, 1979·Immunological Reviews·E SakselaP Häyry
Feb 1, 1979·International Journal of Cancer. Journal International Du Cancer·L C AnderssonC G Gahmberg
Sep 1, 1979·Clinical Immunology and Immunopathology·G K Schwarting, D M Marcus
Dec 15, 1979·International Journal of Cancer. Journal International Du Cancer·L C AnderssonP Vuopio
Mar 22, 1979·Nature·L C AnderssonC G Gahmberg
Sep 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·D M MarcusS K Kundu
Mar 7, 1975·Brain Research·E Godaux, J E Desmedt
Nov 4, 1975·Biochemistry·M NaikiD M Marcus
Oct 1, 1973·Journal of Neurochemistry·R W LedeenL F Eng
Nov 1, 1965·Journal of the American Oil Chemists' Society·A N Siakotos
Jan 1, 1980·Journal of Neurochemistry·S K KunduR W Veh
Feb 1, 1980·Scandinavian Journal of Haematology·L C AnderssonC G Gahmberg
Jan 1, 1981·Immunological Communications·R A KarolD M Marcus
Dec 1, 1980·Journal of Immunogenetics·S K KunduD M Marcus
Oct 1, 1981·Journal of Immunogenetics·S K KunduD M Marcus
Nov 1, 1980·Revue française de transfusion et immuno-hématologie·R A KarolD M Marcus
Jun 1, 1957·Biochimica Et Biophysica Acta·L SVENNERHOLM
Citations
Apr 24, 2001·Transfusion·L L CoolingT A Koerner
May 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·R KannagiS Hakomori
Jul 1, 1987·British Journal of Haematology·E ZdebskaJ Kościelak
Jun 14, 2013·Proceedings of the Japan Academy. Series B, Physical and Biological Sciences·Donald M Marcus
Jun 18, 2014·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Un-Ho JinCheorl-Ho Kim
Aug 12, 2008·Proteomics·Sung-Koo KangCheorl-Ho Kim
May 1, 1986·British Journal of Haematology·A E von dem BorneP A Tetteroo
Nov 19, 1985·Biochemistry·J BuehlerB A Macher
Sep 29, 1995·The Journal of Biological Chemistry·J P YanP Melançon
Oct 24, 2002·Blood·Laura L W CoolingTheodore A W Koerner
Jul 15, 1983·International Journal of Cancer. Journal International Du Cancer·J A WerkmeisterJ C Roder
Aug 15, 1982·International Journal of Cancer. Journal International Du Cancer·Y TomitaT Kuwata
Oct 27, 2017·Oncotarget·Sun-Hyung HaCheorl-Ho Kim
Jul 15, 1987·International Journal of Cancer. Journal International Du Cancer·I AndoR F Irie
Jun 10, 2020·Toxins·Johanna DetznerJohannes Müthing
Jul 21, 1992·Biochimica Et Biophysica Acta·M KotaniT Tai